Dietary Nucleotides

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: immunity digestion longevity

Research Overview

Research on dietary nucleotides has been most developed in animal nutrition and health, particularly around periods of physiological stress or rapid tissue turnover. The largest and most detailed body of work in the studies reviewed here concerns gastrointestinal development and post-weaning adaptation in pigs, where nucleotides are evaluated as antibiotic alternatives to mitigate weaning-associated intestinal dysfunction. Additional studied areas include aquaculture species (rainbow trout and zebrafish), focusing on growth performance, stress physiology, and metabolic regulation, and a smaller but clinically oriented veterinary application in dogs with canine leishmaniosis, where nucleotides are used as part of an immunomodulatory supplement strategy. Across these models, outcomes commonly assessed include growth and feed efficiency, intestinal morphology and nutrient digestibility, inflammatory and oxidative stress markers, stress hormones (e.g., cortisol), and—in zebrafish—whole-animal bioenergetics and microbiota-mediated effects.

The strongest evidence in these studies supports a role for dietary nucleotides in improving performance and aspects of host resilience under challenge conditions, with effects that appear to involve gut function and immune/inflammatory modulation. In newly weaned pigs, controlled dose-response supplementation was associated with improved early feed intake and growth, improved villus architecture (with a quadratic response), reduced jejunal inflammatory signaling (e.g., IL-6 at moderate doses), and improved ileal digestibility of energy and fat—collectively consistent with enhanced intestinal function during weaning stress. In fish, nucleotide supplementation improved growth/feed efficiency and attenuated acute stress responses (lower cortisol and glucose under handling/crowding), suggesting benefits to stress tolerance and physiological stability. Mechanistic evidence is most explicit in zebrafish, where nucleotides increased energy gain while lowering standard metabolic rate and inflammatory tone; microbiota transfer experiments further indicate that at least part of the metabolic effect is mediated indirectly through nucleotide-shaped intestinal microbiota rather than direct host exposure alone. In dogs with leishmaniosis, an open-label controlled trial suggests that a nucleotide+AHCC regimen (with antimonial therapy) can yield clinical improvement comparable to allopurinol-based therapy while avoiding allopurinol-associated xanthinuria, supporting potential utility as an alternative or adjunct in cases where standard therapy is limited by adverse effects.

Key gaps remain regarding generalizability, mechanisms, and translation across species and contexts. Dose optimization and formulation effects require further work, as pig outcomes suggest non-linear responses and potentially diminishing or different effects at higher inclusion levels. Mechanistically, more research is needed to connect nucleotide supplementation to specific microbial taxa/functions, host epithelial turnover dynamics, immune pathways, and energy metabolism in a causal manner across species, and to determine when benefits depend on stressors (weaning, infection, handling) versus baseline conditions. In clinical veterinary contexts, stronger evidence would require blinded, adequately powered trials with standardized co-therapies, longer follow-up, and clearer immunological endpoints to interpret changes such as antibody titers alongside clinical outcomes and parasite burden. Overall, the field supports dietary nucleotides as functional nutrients with plausible gut-immune-metabolic benefits, but broader replication, mechanistic resolution, and context-specific dosing guidance are needed.

1. What conditions has Dietary Nucleotides been studied for?

  • Post-weaning intestinal dysfunction and growth lag in pigs (a period associated with intestinal inflammation, oxidative stress, villus/crypt changes, diarrhea risk, and reduced feed intake).

    • Studied in newly weaned pigs with graded nucleotide inclusion (e.g., 0–500 mg/kg for 21 days; and 0–1.0 g/kg for 28 days with a 5′IMP-rich mixture).

  • Weaning-associated gut and health disturbances in piglets (review context), including intestinal morphology/function, microbiota changes, immune function, nutrient metabolism, and growth performance.

  • Canine leishmaniosis (clinical disease) as an adjunct/alternative immunomodulatory strategy when combined with active hexose correlated compound (AHCC), alongside initial antimonial therapy (methylglucamine antimoniate, MGA).

  • Subclinical Leishmania infantum infection in dogs (prevention/delay of progression to clinical disease) using nucleotides + AHCC vs placebo.

  • Fish growth performance and stress resilience (rainbow trout fingerlings under handling/crowding stress; zebrafish growth and bioenergetic mechanisms involving microbiota).

2. Does it work in treating those conditions? Summarize the evidence.

  • Weaned pigs: evidence supports improved growth and markers of gut health, with dose-dependent effects.

    • In 19-day-old pigs fed nucleotides for 21 days, supplementation increased feed intake in phase 1 and improved growth (ADG) at 50–150 mg/kg in phase 1; overall ADFI increased and overall ADG trended upward. Jejunal IL-6 decreased at 50–150 mg/kg, villus height:crypt ratio showed a quadratic response (peak around ~247 mg/kg), and ileal digestibility of energy and ether extract increased at 50–150 mg/kg.

    • In a 28-day nursery pig study using a nucleotide mixture high in inosine 5′-monophosphate (5′IMP), ADG and ADFI increased linearly up to 1.0 g/kg over the full trial. Some immune/oxidative stress markers suggested potential benefit around 0.5 g/kg (e.g., lowest oxidative DNA damage marker 8-OHdG trend; TNF-α trend downward; diarrhea scores tended to be lowest at 0.5 g/kg after diet phase change).

    • Limitations: these are relatively short-term studies in production animals; outcomes are performance and biomarkers rather than clinical disease endpoints, and optimal dosing appears context- and formulation-dependent.

  • Canine leishmaniosis (clinical): nucleotides + AHCC performed similarly to allopurinol in one open-label controlled trial when both groups received initial MGA.

    • In a multicenter, randomized, open-label, positively controlled trial (final analyses: allopurinol n=29; supplement n=24), both groups improved in clinical scores and antibody titers after treatment. At 180 days, the supplement group had a lower clinical score (P=0.005) and higher antibody titers (P=0.032) than allopurinol. Parasite loads decreased in both groups without significant between-group differences.

    • Interpretation: clinical improvement was comparable, but the antibody-titer direction is mixed (higher titers in the supplement group at day 180 despite better clinical score). The open-label design increases risk of bias.

  • Subclinical Leishmania-infected dogs (prevention): evidence suggests reduced progression to clinical disease with nucleotides + AHCC.

    • In a multicenter, randomized, double-blind, placebo-controlled trial over 365 days, fewer dogs progressed to clinical disease in the supplement group (15%, 3/20) vs placebo (45.5%, 10/22; P=0.047). Antibody titers decreased vs baseline at all time points with supplement (P<0.01) but not placebo; clinical severity score was lower at 180 days (P=0.014).

    • Limitations: modest sample size; supplement included both nucleotides and AHCC, so the independent contribution of nucleotides cannot be isolated.

  • Fish: evidence supports improved growth and stress-response modulation.

    • Rainbow trout fed 0.15–0.2% nucleotides for 8 weeks had better weight gain and feed efficiency; under handling/crowding stress, fish fed 0.2% had significantly lower cortisol than controls, and glucose was lower with nucleotide diets.

    • Zebrafish fed 0.1% mixed nucleotides for 2 weeks had higher weight/energy gain and a 28% lower standard metabolic rate; microbiota transfer experiments suggested the effect depended on microbiota (direct nucleotide feeding in germ-free fish did not replicate the metabolic-rate reduction).

3. What health benefits does it have?

  • Gut structure and function (especially during weaning stress)

    • Improved jejunal villus architecture (quadratic improvement in villus height:crypt ratio in weaned pigs).

    • Improved ileal digestibility of energy and fat (ether extract) at 50–150 mg/kg in newly weaned pigs.

  • Reduced inflammatory and oxidative stress signals (context-dependent)

    • Lower jejunal IL-6 in pigs at 50–150 mg/kg; TNF-α tended to decrease in the 5′IMP-rich pig study; oxidative stress markers showed favorable trends (e.g., plasma MDA quadratic trend in one pig study; 8-OHdG quadratic trend with lowest damage around 0.5 g/kg in another).

    • Zebrafish data suggest nucleotides can reduce “inflammatory tone,” associated with reduced metabolic rate, mediated by intestinal microbiota.

  • Growth and feed intake/performance

    • In pigs, increased ADFI and improved ADG in early post-weaning periods; linear improvements in ADG/ADFI up to 1.0 g/kg in the 5′IMP-rich mixture study.

    • In trout and zebrafish, improved growth metrics at certain inclusion levels (e.g., 0.15–0.2% in trout; 0.1% in zebrafish).

  • Stress resilience (fish) and potential immune modulation (dogs)

    • Trout: lower cortisol and glucose responses under handling/crowding stress with nucleotide supplementation.

    • Dogs with leishmaniosis: improved clinical scores and changes in immune parameters (e.g., increased CD4+/CD8+ ratio reported in both allopurinol and supplement groups in the clinical trial), with preventive benefit in subclinical infection when combined with AHCC.

4. Does it have any downsides or side effects?

  • In the studies reviewed here, dietary nucleotide supplementation was generally well tolerated.

    • In the 365-day placebo-controlled trial in subclinically infected dogs, the supplement (nucleotides + AHCC) was reported as well tolerated.

    • In the clinical leishmaniosis trial, xanthinuria occurred in 41% of dogs on allopurinol vs 0% on nucleotides + AHCC (P=0.000), suggesting the supplement avoided a key adverse effect of standard therapy.

  • Potential trade-offs/uncertainties

    • In pigs, some outcomes were non-linear by dose (e.g., villus height:crypt ratio quadratic; oxidative markers showing trends), implying that “more” may not always be “better,” and optimal dosing may vary by formulation and context.

    • In the canine clinical trial, the supplement group had higher antibody titers at 180 days despite better clinical scores; the clinical meaning of this discordance is unclear from the study alone.

    • Most evidence here is in animals; human safety/side-effect conclusions cannot be inferred from these studies.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

No pharmacogenomic or genotype-stratified findings are reported in the studies reviewed here.

  • The dog studies discuss drug-related adverse events (e.g., allopurinol-associated xanthinuria) and parasite resistance to allopurinol, but they do not link response to host genetic variants.

  • The fish and pig studies evaluate physiological and microbiota-mediated mechanisms, not genetic subgroups.

Overall, based on these studies alone, there is insufficient evidence to claim dietary nucleotides are specifically beneficial or harmful for any particular genetic variation.

References

  1. Supplemental effects of dietary nucleotides on intestinal health and growth performance of newly weaned pigs.
    Ki Beom Jang, Sung Woo Kim (2019) - Journal of animal science
  2. The role of dietary nucleotides in single-stomached animals.
    Nadja Sauer, Rainer Mosenthin, Eva Bauer (2011) - Nutrition research reviews
  3. Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis.
    Sergi Segarra, Guadalupe Miró, Ana Montoya, Luis Pardo-Marín, Noemí Boqué, Lluis Ferrer, José Cerón (2017) - Veterinary parasitology
  4. Effects of dietary nucleotides supplementation on rainbow trout (Oncorhynchus mykiss) performance and acute stress response.
    Ahmad Tahmasebi-Kohyani, Saeed Keyvanshokooh, Amin Nematollahi, Nemat Mahmoudi, Hossein Pasha-Zanoosi (2012) - Fish physiology and biochemistry
  5. The Growth-Promoting Effect of Dietary Nucleotides in Fish Is Associated with an Intestinal Microbiota-Mediated Reduction in Energy Expenditure
    Xiaoze Guo, Chao Ran, Zhen Zhang, Suxu He, Min Jin (2017)
  6. Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound.
    Sergi Segarra, Guadalupe Miró, Ana Montoya, Luis Pardo-Marín, Joan Teichenné, Lluís Ferrer, José Joaquín Cerón (2018) - Parasites & vectors
  7. Supplemental nucleotides high in inosine 5'-monophosphate to improve the growth and health of nursery pigs.
    A C Weaver, S W Kim (2014) - Journal of animal science
  8. New immunomodulatory treatment protocol for canine leishmaniosis reduces parasitemia and proteinuria.
    Guadalupe Miró, Sergi Segarra, José Joaquín Cerón, Lluís Ferrer, Laia Solano-Gallego, Laia Montell, Ester Costa, Joan Teichenne, Roger Mariné-Casadó, Xavier Roura (2024) - PLoS neglected tropical diseases
  9. Dietary administration of nucleotides to enhance growth, humoral immune responses, and disease resistance of the rainbow trout (Oncorhynchus mykiss) fingerlings.
    Ahmad Tahmasebi-Kohyani, Saeed Keyvanshokooh, Amin Nematollahi, Nemat Mahmoudi, Hossein Pasha-Zanoosi (2011) - Fish & shellfish immunology
  10. Dietary Nucleotides Alleviate Hepatic Lipid Deposition via Exogenous AMP-Mediated AMPK Activation in Zebrafish.
    Chao Ran, Mingxu Xie, Jie Li, Yadong Xie, Qianwen Ding, Yu Li, Wei Zhou, Yalin Yang, Zhen Zhang, Rolf Erik Olsen, Zhigang Zhou (2021) - The Journal of nutrition
  11. Impact of dietary-nucleotides and Saccharomyces cerevisiae-derivatives on growth-performance, antioxidant-capacity, immune-response, small-intestine histomorphometry, caecal-
    Tamer Mohamed Abo-Sriea, Elshaimaa Ismael, Basant Mohsen Sobhi, Neven H Hassan, Ebtihal M M Elleithy, Sherif AbdElmonam Omar, Ahmed M Soliman, Khaled Nasr El-Din Fahmy, Amer Ramadan (2024) - International journal of veterinary science and medicine
  12. The impact of exogenous dietary nucleotides in ameliorating
    F F Mohamed, Maha M Hady, N F Kamel, Naela M Ragaa (2020) - Veterinary and animal science
  13. Use of a commercial feed supplement based on yeast products and microalgae with or without nucleotide addition in calves.
    Aristide Maggiolino, Gerardo Centoducati, Elisabetta Casalino, Gabriella Elia, Tiziana Latronico, Maria Grazia Liuzzi, Luigi Macchia, Geoffrey E Dahl, Gianluca Ventriglia, Nicola Zizzo, Pasquale De Palo (2023) - Journal of dairy science
  14. Additional effect of perioperative, compared with preoperative, immunonutrition after pancreaticoduodenectomy: A randomized, controlled trial.
    Youhei Miyauchi, Katsunori Furukawa, Daisuke Suzuki, Hideyuki Yoshitomi, Tsukasa Takayashiki, Satoshi Kuboki, Masaru Miyazaki, Masayuki Ohtsuka (2019) - International journal of surgery (London, England)
  15. Response to an Escherichia coli K88 oral challenge and productivity of weanling pigs receiving a dietary nucleotides supplement.
    Hanlin Li, Pinyao Zhao, Yan Lei, Tianshui Li, InHo Kim (2015) - Journal of animal science and biotechnology
  16. The effects of pure nucleotides on performance, humoral immunity, gut structure and numbers of intestinal bacteria of newly weaned pigs.
    N Sauer, M Eklund, E Bauer, M G Gänzle, C J Field, R T Zijlstra, R Mosenthin (2012) - Journal of animal science
  17. Nutritional Modulation of the Immune Response Mediated by Nucleotides in Canine Leishmaniosis.
    Sergi Segarra (2021) - Microorganisms
  18. Dietary nucleotides influence immune responses and intestinal morphology of red drum Sciaenops ocellatus.
    Zhenyan Cheng, Alejandro Buentello, Delbert M Gatlin (2011) - Fish & shellfish immunology
  19. Dietary nucleotides can prevent glucocorticoid-induced telomere attrition in a fast-growing wild vertebrate.
    Stefania Casagrande, Jasmine L Loveland, Marlene Oefele, Winnie Boner, Sara Lupi, Antoine Stier, Michaela Hau (2023) - Molecular ecology
  20. Effects of dietary yeast nucleotides on growth, non-specific immunity, intestine growth and intestinal microbiota of juvenile hybrid tilapia
    Li Xu, Chao Ran, Suxu He, Jianli Zhang, Jun Hu, Yalin Yang, Zhenyu Du, Yanou Yang, Zhigang Zhou (2015) - Animal nutrition (Zhongguo xu mu shou yi xue hui)


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!